Obesity and Dyslipidemia

Area of Science:

• Metabolic Disorders
• Cardiovascular Health
• Obesity Medicine

Background:

• Obesity frequently co-occurs with dyslipidemia, characterized by lipid metabolism disorders.
• Abdominal obesity significantly elevates cardiometabolic risk due to atherogenic dyslipidemia, even with normal total LDL-C.
• Low-density lipoprotein cholesterol (LDL-C) is a primary treatment target, with Apoliprotein B (Apo B) and non-high-density lipoprotein cholesterol (non-HDL-C) as secondary goals for precise cardiovascular risk assessment.

Purpose of the Study:

• To summarize the pathophysiological consequences linking obesity and dyslipidemia.
• To present practical management approaches for these interconnected conditions.

Main Methods:

• Review of current literature on obesity and dyslipidemia pathophysiology.
• Analysis of the impact of weight loss interventions on lipid profiles.
• Evaluation of nutrient composition and bariatric surgery effects on lipid metabolism.

Main Results:

• Weight loss interventions (diet, medication) effectively decrease triglycerides (TG) and LDL-C while increasing HDL-C.
• Nutrient composition, particularly fatty acids, plays a role in modulating lipid levels.
• Bariatric surgery demonstrates significant efficacy in both weight reduction and improving serum lipid profiles.

Conclusions:

• Obesity and dyslipidemia are common, intertwined diseases requiring integrated management.
• Effective management is crucial for mitigating cardiovascular risk and obesity-related complications.
• Targeted interventions can favorably alter lipid profiles and reduce overall health risks.